30
Participants
Start Date
November 30, 2009
Primary Completion Date
June 30, 2011
Study Completion Date
June 30, 2011
L-ornithine-L-aspartate
a) Intravenous infusion of 20 g L-ornithine-L-aspartate (4 ampules of 10 mL each) in 250 mL sodium chloride solution administered daily in 4 hours for 3 consecutive days, plus the placebo b) Water enemas, 1000 mL of water and given as retention enema every 12 hours for 3 consecutive days.
Lactose
a) 20% Lactose enemas, 200 g Lactose diluted with 700 mL of water and given as retention enema every 12 hours for 3 consecutive days, plus intravenous placebo b)250 mL sodium chloride solution, infusion for 4 hours for 3 consecutive days.
"Hospital Universitario José Eleuterio González", Monterrey
Collaborators (1)
MERZ PHARMA
UNKNOWN
Centro Regional para el Estudio de las Enfermedades Digestivas
OTHER